TSW
Thompson Siegel & Walmsley’s Anika Therapeutics ANIK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1
| Closed | – | – | 650 |
|
|
2019
Q4 | $0 | Sell |
1
-70
| -99% | – | ﹤0.01% | 791 |
|
|
2019
Q3 | $4K | Sell |
71
-48,531
| -100% | -$2.73M | ﹤0.01% | 692 |
|
|
2019
Q2 | $1.97M | Sell |
48,602
-10,410
| -18% | -$423K | 0.03% | 206 |
|
|
2019
Q1 | $1.79M | Buy |
59,012
+3,840
| +7% | +$116K | 0.03% | 215 |
|
|
2018
Q4 | $1.86M | Buy |
55,172
+29,685
| +116% | +$998K | 0.03% | 207 |
|
|
2018
Q3 | $1.08M | Buy |
+25,487
| New | +$1.08M | 0.01% | 299 |
|
|
2017
Q4 | – | Sell |
-66
| Closed | -$4K | – | 828 |
|
|
2017
Q3 | $4K | Sell |
66
-196,016
| -100% | -$11.9M | ﹤0.01% | 791 |
|
|
2017
Q2 | $9.68M | Sell |
196,082
-84,720
| -30% | -$4.18M | 0.11% | 192 |
|
|
2017
Q1 | $12.2M | Sell |
280,802
-217,661
| -44% | -$9.46M | 0.14% | 177 |
|
|
2016
Q4 | $24.4M | Sell |
498,463
-95,075
| -16% | -$4.65M | 0.32% | 96 |
|
|
2016
Q3 | $28.4M | Sell |
593,538
-6,993
| -1% | -$335K | 0.44% | 81 |
|
|
2016
Q2 | $32.2M | Sell |
600,531
-162,265
| -21% | -$8.71M | 0.51% | 69 |
|
|
2016
Q1 | $34.1M | Sell |
762,796
-213,704
| -22% | -$9.56M | 0.55% | 68 |
|
|
2015
Q4 | $37.3M | Sell |
976,500
-102,602
| -10% | -$3.92M | 0.67% | 40 |
|
|
2015
Q3 | $34.3M | Buy |
1,079,102
+32,349
| +3% | +$1.03M | 0.64% | 46 |
|
|
2015
Q2 | $34.6M | Buy |
1,046,753
+368,395
| +54% | +$12.2M | 0.61% | 44 |
|
|
2015
Q1 | $27.9M | Buy |
678,358
+21,328
| +3% | +$878K | 0.48% | 66 |
|
|
2014
Q4 | $26.8M | Buy |
657,030
+60,788
| +10% | +$2.48M | 0.51% | 60 |
|
|
2014
Q3 | $21.9M | Buy |
596,242
+332,620
| +126% | +$12.2M | 0.44% | 78 |
|
|
2014
Q2 | $12.2M | Buy |
263,622
+262,822
| +32,853% | +$12.2M | 0.24% | 180 |
|
|
2014
Q1 | $33K | Hold |
800
| – | – | ﹤0.01% | 491 |
|
|
2013
Q4 | $31K | Hold |
800
| – | – | ﹤0.01% | 491 |
|
|
2013
Q3 | $19K | Hold |
800
| – | – | ﹤0.01% | 521 |
|
|
2013
Q2 | $14K | Buy |
+800
| New | +$14K | ﹤0.01% | 551 |
|